BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2645558)

  • 41. [Lymph node staging in prostatic carcinoma Lymphography, pedal and intraprostatic lymphoscintigraphy, transcutaneous fine-needle lymph node biopsy and pelvic "guided" lymphadenectomy. Considerations on a series of 20 cases (1 September 1978-31 January 1980)].
    Luciani L; Menichelli E; Fuochi C; Taddei L
    Minerva Med; 1981 Apr; 72(13):789-800. PubMed ID: 7012680
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The efficacy of bone scintigraphy screening in postoperative follow-up of breast cancer patients].
    Ohnari N; Shiozaki H; Ishino Y; Nakata H
    Gan No Rinsho; 1990 Dec; 36(15):2546-8. PubMed ID: 2266587
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Skeletal scintigraphy in the care of breast cancer . Long-term follow-up over 8 years].
    Anger K; Möller T; Zeimantz E
    Strahlentherapie; 1983 Dec; 159(12):745-50. PubMed ID: 6665812
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Skeletal scintigraphy in the follow-up of breast cancer. Statistical and epidemiological viewpoints].
    Hölzel D; Thieme C
    Dtsch Med Wochenschr; 1986 Aug; 111(31-32):1191-9. PubMed ID: 3732072
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Breast cancer: the role of scintigraphy in the initial evaluation and follow-up of patients with small tumors (T less than or equal to 3 cm)].
    Lagrange JL; Hoch M; Courdi A; Darcourt J; Benoiel J; Namer M; Hery M; Abbes M; Monticelli J; Schneider M
    Bull Cancer; 1988; 75(3):271-80. PubMed ID: 3370323
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Using PSA to eliminate the staging radionuclide bone scan. Significant economic implications.
    Oesterling JE
    Urol Clin North Am; 1993 Nov; 20(4):705-11. PubMed ID: 7505979
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Experimental and clinical investigations of bone scintigraphy using 99mTc methylene diphosphonate kit].
    Tonami N; Seto M; Ueno K; Kubota A; Hisada K
    Kaku Igaku; 1977 Dec; 14(6):911-21. PubMed ID: 614448
    [No Abstract]   [Full Text] [Related]  

  • 48. [X-ray survey and radioisotope scanning of the skeleton in the evaluation of bone metastases in prostatic carcinoma].
    Meiraz D; Garti I; Lubin E
    Harefuah; 1978 Nov; 95(10):332-3. PubMed ID: 570535
    [No Abstract]   [Full Text] [Related]  

  • 49. [Recent advances in isotopic exploration of the skeletal system in prostate cancer (author's transl)].
    Oliveux A; Grob JC; Moyses B; Methlin G; Bollack C
    Sem Hop; 1980 Feb 18-25; 56(7-8):346-50. PubMed ID: 6246630
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Skeletal scintigraphy.
    McDougall IR
    West J Med; 1979 Jun; 130(6):503-14. PubMed ID: 390886
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Rationalization profits of radiographic diagnosis with systematic follow-up DBCG (Danish Breast Cancer Cooperative Group) programs. 1].
    Thomsen HS; Andersen JA; Andersen KW; Axelsson CK; Blichert-Toft M; Dombernowsky P; Hansen M; Krag C; Mouridsen HT; Overgaard M
    Ugeskr Laeger; 1991 Aug; 153(33):2270-2. PubMed ID: 1781044
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The problem of false positives in bone scintigraphy in patients with breast neoplasms. A follow-up at 10 years].
    Campostrini F; Di Marco A; Micciolo R; Grandinetti A; Griso C; Palazzi M; Zamboni M
    Radiol Med; 1990 May; 79(5):539-43. PubMed ID: 2113699
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Editorial comment.
    Cooperberg MR
    Urology; 2011 Jun; 77(6):1336-7. PubMed ID: 21624594
    [No Abstract]   [Full Text] [Related]  

  • 54. Nasopharyngeal carcinoma: value of bone and liver scintigraphy in the pre-treatment and follow-up period.
    Kraiphibul P; Atichartakarn V; Clongsusuek P; Kulapaditharom B; Ratanatharathorn V; Chokewattanaskul P
    J Med Assoc Thai; 1991 Jul; 74(7):276-9. PubMed ID: 1662680
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Early recognition of bone metastases (comparative study between bone scintigraphy and x-ray examination)].
    Fochem K; Ogris E
    Acta Med Austriaca; 1976; 3(5):170-6. PubMed ID: 1020632
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bone scan index: A new biomarker of bone metastasis in patients with prostate cancer.
    Nakajima K; Edenbrandt L; Mizokami A
    Int J Urol; 2017 Sep; 24(9):668-673. PubMed ID: 28556293
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pelvic lipomatosis detected on bone scintigraphy.
    Sam JW; Alavi A; Banner MP; Ramchandani P
    AJR Am J Roentgenol; 2004 Jun; 182(6):1604-5. PubMed ID: 15150024
    [No Abstract]   [Full Text] [Related]  

  • 58. Proceedings: Diagnosis and staging of prostatic carcinoma.
    Prout GR
    Cancer; 1973 Nov; 32(5):1096-103. PubMed ID: 4202187
    [No Abstract]   [Full Text] [Related]  

  • 59. [Unusual, unilateral metastasis of a prostate-carcinoma and palliative rhenium-186 pain-therapy].
    Breidert-Backes I; Adams S; Baum RP; Hör G
    Nuklearmedizin; 1997 Dec; 36(8):289-91. PubMed ID: 17068880
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Absent kidney sign in the bone scintigraphy].
    Odano I; Sato Y; Kimura M; Sakai K
    Rinsho Hoshasen; 1984 Nov; 29(12):1453-4. PubMed ID: 6521011
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.